Edesa Biotech

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-51
-45
EBITDA
-1,554
-922
-1,616
-1,815
EBIT
-1,597
-967
-1,668
-1,860
Net Income
-1,617
-962
-1,668
-1,861
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,517
-967
-856
-1,675
Cash
1,563
1,037
2,040
2,799
Basic Shares
3,345
3,247
3,221
3,192

Annual Financials

Values in thousands 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue
$0
$0
$0
$
Gross Profit
-183
-118
-118
EBITDA
-6,130
-9,222
-17,429
-13,223
EBIT
-6,316
-9,222
-17,548
-13,342
Net Income
-6,170
-8,374
-17,548
-13,343
Net Change In Cash
0
0
0
Free Cash Flow
-4,890
-6,636
-12,284
-13,671
Cash
1,037
5,361
7,090
7,839
Basic Shares
3,197
2,858
2,096
1,725

Earnings Calls

Quarter EPS
2024-12-31
-$0.48
2024-09-30
-$0.29
2024-06-30
-$0.52
2024-03-31
-$0.58